PF-06700841
98%
- Product Code: 101953
CAS:
1883299-62-4
| Molecular Weight: | 389.4 g./mol | Molecular Formula: | C₁₈H₂₁F₂N₇O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
PF-06700841 is primarily investigated for its potential therapeutic applications in treating autoimmune and inflammatory diseases. It functions as a dual inhibitor of TYK2 and JAK1, which are key enzymes involved in signaling pathways that regulate immune responses. By targeting these enzymes, PF-06700841 can modulate the activity of cytokines that drive inflammation, making it a promising candidate for conditions such as psoriasis, rheumatoid arthritis, and inflammatory bowel disease. Clinical trials have explored its efficacy and safety in reducing disease symptoms and improving patient outcomes. Its ability to selectively inhibit specific JAK pathways may also offer a favorable safety profile compared to broader JAK inhibitors. Ongoing research continues to evaluate its potential in other immune-mediated disorders.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿13,608.00 |
+
-
|
| 0.010 | 10-20 days | ฿19,440.00 |
+
-
|
PF-06700841
PF-06700841 is primarily investigated for its potential therapeutic applications in treating autoimmune and inflammatory diseases. It functions as a dual inhibitor of TYK2 and JAK1, which are key enzymes involved in signaling pathways that regulate immune responses. By targeting these enzymes, PF-06700841 can modulate the activity of cytokines that drive inflammation, making it a promising candidate for conditions such as psoriasis, rheumatoid arthritis, and inflammatory bowel disease. Clinical trials have explored its efficacy and safety in reducing disease symptoms and improving patient outcomes. Its ability to selectively inhibit specific JAK pathways may also offer a favorable safety profile compared to broader JAK inhibitors. Ongoing research continues to evaluate its potential in other immune-mediated disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :